Validation of standardized training system for robot-assisted radical prostatectomy: comparison of perioperative and surgical outcomes between experienced surgeons and novice surgeons at a low-volume institute in Japan

Kato, Daisuke; Namiki, Sanae; Shota, Ueda; Takeuchi, Yasumichi; Takeuchi, Shinichi; Kawase, Makoto; Kawase, Kota; Nakai, Chie; Takai, Manabu; Iinuma, Koji; Nakane, Keita; Koie, Takuya

doi:10.1080/13645706.2022.2056707

Cited by 6 publications

(6 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For these reasons, the experience of RARP under supervision may be helpful in acquiring optimal surgical and perioperative outcomes for novice surgeons or residents. 25 In our series, perioperative complication rates were similar to those previously reported. [26][27][28] From the experience at Henry Ford Hospital with 2766 patients who underwent RARP, Clavien-Dindo complications of grade I-II occurred in 11.7%, grade III-IV in 0.51%, and grade V in <0.01% of patients.…”

Section: Discussionsupporting

confidence: 90%

“…In our series, perioperative complication rates were similar to those previously reported 26–28 . From the experience at Henry Ford Hospital with 2766 patients who underwent RARP, Clavien–Dindo complications of grade I–II occurred in 11.7%, grade III–IV in 0.51%, and grade V in <0.01% of patients 25 . According to an analysis of postoperative complications in 3317 patients who underwent RRP, 264 patients (8.0%) developed 289 surgery‐related complications, including 242 minor (Clavien–Dindo I–II) and 126 major (Clavien–Dindo III–V) complications 26 .…”

Section: Discussionsupporting

confidence: 89%

“…In contrast, the rates of PSM were 29.5% and 29.7%, respectively ( P = .922). For these reasons, the experience of RARP under supervision may be helpful in acquiring optimal surgical and perioperative outcomes for novice surgeons or residents 25 …”

Section: Discussionmentioning

confidence: 99%

“…[26][27][28] From the experience at Henry Ford Hospital with 2766 patients who underwent RARP, Clavien-Dindo complications of grade I-II occurred in 11.7%, grade III-IV in 0.51%, and grade V in <0.01% of patients. 25 According to an analysis of postoperative complications in 3317 patients who underwent RRP, 264 patients (8.0%) developed 289 surgery-related complications, including 242 minor (Clavien-Dindo I-II) and 126 major (Clavien-Dindo III-V) complications. 26 In our opinion, surgical skill is a strong predictor of clinical outcomes, including perioperative complications.…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Short‐term oncological and surgical outcomes of robot‐assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group)

Kato

Ebara

Tatenuma

et al. 2022

Asian J Endoscop Surgery

Self Cite

View full text Add to dashboard Cite

Introduction: We evaluated oncological outcomes of patients undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer (PCa) and their perioperative complications in Japan. We investigated clinical and pathological covariates to predict biochemical recurrence (BCR) after RARP.Methods: A retrospective multicenter cohort study was conducted in RARP patients with PCa at 10 institutions in Japan. Pre-and postoperative covariates were collected from enrolled patients. The primary endpoint was defined as biochemical recurrence-free survival (BRFS). Additionally, the association between BCR and clinicopathological covariates was determined.Results: We enrolled 2670 patients in this study. The median follow-up period was 26.0 months. RARP-related perioperative complications were identified in 198 patients (7.4%), including 69 patients (2.6%) with grade 3/4 complications according to the Clavien-Dindo classification. The 2-year BRFS was 88.0%.Using the Kaplan-Meier method, initial prostate-specific antigen (PSA) level of ≤7.6 ng/mL, biopsy and pathological Gleason score (GS) of ≤7, clinical and pathological T1/2, and low/intermediate risks according to the National Comprehensive Cancer Network risk classification, and negative surgical margin status had significant BRFS than their counterparts. In multivariate analysis, initial PSA, biopsy and pathological GS, clinical and pathological T stage, and surgical margin status significantly correlated with BCR after RARP. Conclusion: In this study, RARP achieved a lower incidence of perioperative complications than other studies. K E Y W O R D Soncological outcomes and perioperative complications, prostate cancer, robot-assisted radical prostatectomy

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionsupporting

confidence: 89%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Short‐term oncological and surgical outcomes of robot‐assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group)

Kato

Ebara

Tatenuma

et al. 2022

Asian J Endoscop Surgery

Self Cite

View full text Add to dashboard Cite

show abstract

“…All patients underwent computed tomography and magnetic resonance imaging prior to RARP, confirming the absence of levator muscle invasion, locoregional and distant lymph node involvement, and distant metastases. All enrolled in the study did not undergo pelvic lymph node dissection (PLND) for the reasons we have previously reported [ 27 , 28 ].…”

Section: Methodsmentioning

confidence: 99%

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer

Sugino

Nakane

Kawase

et al. 2023

Life

Self Cite

View full text Add to dashboard Cite

Background: This retrospective single-center cohort study evaluated the efficacy and safety of a combination of neoadjuvant luteinizing hormone-releasing hormone (LHRH) antagonist and tegafur-uracil (UFT) therapy (NCHT) and investigated the medical records of patients with high-risk PCa who underwent robot-assisted radical prostatectomy (RARP). The therapy was followed by RARP for high-risk PCa. Materials and Methods: The enrolled patients were divided into two groups: low-intermediate-risk PCa patients who underwent RARP without neoadjuvant therapy (non-high-risk) and those who underwent NCHT followed by RARP (high-risk group). This study enrolled 227 patients (126: non-high-risk and 101: high-risk group). Patients in the high-risk-group had high-grade cancer compared to those in the non-high-risk-group. Results: At the median follow-up period of 12.0 months, there were no PCa deaths; two patients (0.9%) died of other causes. Twenty patients developed biochemical recurrence (BCR); the median time until BCR was 9.9 months after surgery. The 2-year biochemical recurrence-free survival rates were 94.2% and 91.1% in the non-high-risk and high-risk-group, respectively (p = 0.465). Grade ≥3 NCHT-related adverse events developed in nine patients (8.9%). Conclusions: This study indicates that combining neoadjuvant LHRH antagonists and UFT followed by RARP may improve oncological outcomes in patients with high-risk PCa.

show abstract

Predictors of surgical difficulty according to surgical proficiency in robot-assisted radical prostatectomy

Uchida,

Hasegawa,

Umemoto

et al. 2024

Surg Endosc

View full text Add to dashboard Cite

Validation of standardized training system for robot-assisted radical prostatectomy: comparison of perioperative and surgical outcomes between experienced surgeons and novice surgeons at a low-volume institute in Japan

Cited by 6 publications

References 31 publications

Short‐term oncological and surgical outcomes of robot‐assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group)

Short‐term oncological and surgical outcomes of robot‐assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group)

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer

Predictors of surgical difficulty according to surgical proficiency in robot-assisted radical prostatectomy

Contact Info

Product

Resources

About